PRE
Prenetics Global Ltd
NASDAQ: PRE · HEALTHCARE · DIAGNOSTICS & RESEARCH
$16.71
-4.02% today
Updated 2026-04-30
Market cap
$310.15M
P/E ratio
—
P/S ratio
3.36x
EPS (TTM)
$-3.79
Dividend yield
—
52W range
$5 – $24
Volume
0.2M
WallStSmart proprietary scores
35
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A5.0
Quality
C+2.0
Profitability
F6.0
Valuation
B—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$31.25
+87.01%
12-Month target
—
—
Intrinsic (DCF)
$25.92
Margin of safety
+17.44%
0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Revenue growth 248.60% QoQ
+ 17.44% below intrinsic value
Risks
- Thin margins at -63.10%
- Negative free cash flow $-22.02M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $13.16M | $21.74M | $30.62M | $92.39M | $92.39M |
| Net income | $-190.45M | $-62.72M | $-46.30M | $-58.32M | $-28.11M |
| EPS | — | — | — | — | $-3.79 |
| Free cash flow | $8.17M | $-14.68M | $-29.94M | $-22.02M | $-22.02M |
| Profit margin | -1,446.78% | -288.48% | -151.22% | -63.13% | -63.10% |
Peer comparison
Smart narrative
Prenetics Global Ltd trades at $16.71. Our Smart Value Score of 35/100 indicates the stock is weak. TTM revenue stands at $92.39M. with profit margins at -63.10%. Our DCF model estimates intrinsic value at $25.92.
Frequently asked questions
What is Prenetics Global Ltd's stock price?
Prenetics Global Ltd (PRE) trades at $16.71.
Is Prenetics Global Ltd overvalued?
Smart Value Score 35/100 (Grade D, Sell). DCF value $25.92.
What is the price target of Prenetics Global Ltd (PRE)?
The analyst target price is $31.25, representing +87.0% upside from the current price of $16.71.
What is the intrinsic value of Prenetics Global Ltd (PRE)?
Based on our DCF model, intrinsic value is $25.92, a +17.4% margin of safety versus $16.71.
What is Prenetics Global Ltd's revenue?
TTM revenue is $92.39M.
Company info
SectorHEALTHCARE
IndustryDIAGNOSTICS & RESEARCH
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio3.36x
ROE-31.80%
Beta0.27
50D MA$18.88
200D MA$14.58
Shares out0.02B
Float0.01B
Short ratio—
Avg volume0.2M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—